The Results of a 24-Month Controlled, Prospective Study of Relapsing Multiple Sclerosis Patients at Risk for Progressive Multifocal Encephalopathy, Who Switched from Prolonged Use of Natalizumab to Teriflunomide
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL（2021）
关键词
relapsing multiple sclerosis,natalizumab,teriflunomide,progressive multifocal leukoencephalopathy,John Cunningham virus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要